Study In Patients With Type 2 Diabetes Who Are Taking Metformin And Sulfonylurea, Metformin And Insulin, Or Insulin
Phase 1
Completed
- Conditions
- Non-Insulin-Dependent Diabetes Mellitus
- Registration Number
- NCT00269061
- Lead Sponsor
- GlaxoSmithKline
- Brief Summary
This study will use Magnetic Resonance Imaging (MRI) techniques to evaluate changes in fluid volume in the lower legs of diabetic patients who add either pioglitazone or placebo to their current diabetic regimen.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 32
Inclusion Criteria
Not provided
Exclusion Criteria
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Changes in interstitial fluid volume in the lower extremities as measured by MRI.
- Secondary Outcome Measures
Name Time Method Assessments of other indicators of fluid volume changes, including labwork evaluation, fluid compartment volume measurement, direct measurement of the calf.
Trial Locations
- Locations (1)
GSK Investigational Site
🇺🇸Belmont, Massachusetts, United States